. . . . . . . . . . . . . "DICYCLOMINE"@en . . . "Dicicloverina"@en . . " "@en . . . "77-19-0"@en . . . . "approved"@en . . . . . . . . . . . . . . . . . "A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms. [PubChem]"@en . "Van Campen, M.G. Jr. and Tilford, C.H.; US.Patent 2,474,796; June 28, 1949; assigned to The Wm. S. Merrell Company."@en . . . . . . . . . . . "Dicycloverine"@en . . . . " "@en . . . . . "For the treatment of functional bowel/irritable bowel syndrome including Colicky abdominal pain; diverticulitis"@en . . "Avoid alcohol."@en . . "Dicyclomine"@en . "The principal route of elimination is via the urine (79.5% of the dose). Excretion also occurs in the feces, but to a lesser extent (8.4%)."@en . ">99%"@en . . . . . . . . "Dicycloverin"@en . . . . . . . . . . . . . . . . . . . . . . . . "Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester"@en . . . . . . . "2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate"@en . . . . . . . . . . "Action is achieved via a dual mechanism: (1) a specific anticholinergic effect (antimuscarinic) at the acetylcholine-receptor sites and (2) a direct effect upon smooth muscle (musculotropic)."@en . "* 3.65 L/kg [20 mg oral dose]"@en . . . . . . . . . . "Humans and other mammals"@en . . . . . . . . . . . . . . . . . . . . . . "Dicycloverinum"@en . . "Take this medication 30 minutes before meals."@en .